Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results

Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
(NASDAQ: CRVS) Delayed: 12.13 +0.53 (4.57%)
Previous Close $11.60    52 Week High $17.77 
Open $11.52    52 Week Low $9.63 
Day High $12.27    P/E N/A 
Day Low $11.50    EPS $0.00 
Volume 291,455